<?xml version="1.0" encoding="UTF-8"?>
<ref id="R34">
 <label>34</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Ross</surname>
    <given-names>AE</given-names>
   </string-name>, 
   <string-name>
    <surname>Hurley</surname>
    <given-names>PJ</given-names>
   </string-name>, 
   <string-name>
    <surname>Tran</surname>
    <given-names>PT</given-names>
   </string-name>, 
   <etal>et al</etal>
  </person-group>. 
  <article-title>A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer</article-title>. 
  <source>Prostate Cancer Prostatic Dis</source>
  <year>2020</year>;
  <volume>23</volume>:
  <fpage>184</fpage>â€“
  <lpage>93</lpage>. 
  <pub-id pub-id-type="doi">10.1038/s41391-019-0176-8</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/31611635?>
  <pub-id pub-id-type="pmid">31611635</pub-id>
 </mixed-citation>
</ref>
